Category: Federal

Bipartisan AG Group Urges Senate to Protect 340B Contract Pharmacy Agreements, Require Provider Transparency

August 3, 2023 Rich Daly Editor in Chief Views

Connecticut Attorney General William Tong (D) led a bipartisan group of state attorneys general urging changes to the 340B program.

Twenty-three state attorneys general urged a group of U.S. senators crafting a legislative overhaul of the 340B program to add [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

On Deadline Day for Senate Feedback, Researchers in JAMA Urge 340B Provider Reporting, Tightening Eligibility, Preventing Drug Overcharges

August 3, 2023 Rich Daly Editor in Chief Views

On the day a group of bipartisan Senators requested feedback from stakeholders, an influential academic and his colleagues published a series of recommendations to reform the 340B program in JAMA

A high-profile researcher and colleagues are urging a range of changes to the 340B program, including new provisions on transparency, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Claims Clearinghouse, Strengthening HRSA Among Few Consensus Areas in Responses to Senate 340B Overhaul Effort

August 1, 2023 Rich Daly Editor in Chief Views

Sen. John Thune is part of a bipartisan group of six senators that solicited stakeholder advice on strategies to reform the 340B program.

The creation of a claims clearinghouse and increasing both the funding and authority of the federal agency overseeing the 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Broad Support Emerges for Adding Duplicate Discount Modifiers to Medicaid Cards

August 1, 2023 Rich Daly Editor in Chief Views

340B stakeholders broadly support adding identifiers to Medicaid drug beneficiaries’ cards to held avoid duplicate 340B discounts, comments on a CMS proposed rule show.

A federal proposal to require the addition of new identifiers to Medicaid drug beneficiaries’ cards to avoid duplicate 340B discounts [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Senate Panel Passes PBM Reform Bill With Medicaid Drug Payment Limits and 340B Reporting Requirements

July 27, 2023 William Newton Washington Correspondent Views

Senate Finance Committee PBM reform bill markup.

The Senate Finance Committee voted 26-1 to pass a PBM reform bill with Medicaid spread pricing language that could result in less 340B savings for covered entities.

The U.S. Senate Finance Committee yesterday voted 26-1 to pass a pharmacy benefit manager reform bill that would cut providers’ [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

100+ Health Centers and Groups Sign Pro-340C Letter to Congress

July 27, 2023 Tom Mirga Editor at Large Views

More than 100 health centers and groups have signed a letter to Congress supporting the 340C initiative.

More than 100 community health centers, state primary care associations, and national and local groups urged congressional leaders this week [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

HRSA Sends Previously Audited 340B Hospital a Second Follow-up Compliance Letter

July 27, 2023 Tom Mirga Editor at Large Views

A HRSA manufacturer audit found that drugmakers Cencora and Medefil Inc. owe repayments to 340B providers.

A hospital that the U.S. Health Resources and Services Administration audited for 340B program compliance and then was one of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

CMS’s 340B Hospital Repayment Plan Leaves Medicare Advantage Cuts Untouched

July 27, 2023 Rich Daly Editor in Chief Views

Attorney Kyle Vasquez says many clients feel they are entitled to a remedy for underpayments from Medicare Advantage plans stemming from CMS' July 7 proposed rule.

The recently proposed Medicare fee-for-service lump sum payments to 340B hospitals to make up for a nearly five-year unlawful rate [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Amgen, Vertex, and AstraZeneca Post 340B Refund and Replenishment Public Notices

July 27, 2023 Tom Mirga Editor at Large Views

Aranesp is among the drugs listed on HRSA's latest manufacturer's notice posted on behalf of Amgen.

The U.S. Health Resources and Services Administration (HRSA) this week published notices from drug makers Amgen and Vertex about refunds [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Large Drug Maker, Big Health System, and Influential Health Center Jointly Lobbying for Senate Bipartisan 340B Initiative

July 25, 2023 Tom Mirga Editor at Large Views

340B Working Table 340B lobbying disclosure form

Under the name 340B Working Table, Genentech, Sanford Health, and Carolina Health Centers are jointly lobbying for a bipartisan U.S. Senate 340B reform initiative.

Biopharmaceutical manufacturer Genentech, South Dakota-based health system Sanford Health, and South Carolina federally qualified health center Carolina Health Centers are jointly lobbying members of Congress to back six U.S. senators’ bipartisan approach to federal 340B program reform, the three organizations

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Exclusive